Dendritic cells: Therapeutic potentials

Transfusion Science

Volumn 18, Issue 2, 1997, Pages 313-326

  Banchereau, J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

CELL DIFFERENTIATION; CELL MIGRATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HEMATOPOIETIC STEM CELL; LYMPHOID ORGAN; MONOCYTE; ORGAN TRANSPLANTATION; REVIEW;

EID: 0347937639     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(97)00022-2     Document Type: Article

References (87)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9 :271-296.
2. Caux C, Banchereau, J: In vitro regulation of dendritic cell development and function, in Whetton T, Gordon J (eds) Blood Cell Biochemistry, London, Plenum Press, 1996, 263-301.
3. Young JW, Inaba K: Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J Exp Med 1996; 183:7-11.
4. Nelson DJ, Holt PG: Defective regional immunity in the respiratory tract of neonates is attributable to hyporesponsiveness of local dendritic cells to activation signals. J Immunol 1995; 155: 3517-3524.
5. Zhou L-J, Schwarting R, Smith HM, Tedder TF: A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 1992; 149:735-742.
6. Williams LA, Egner W, Hart DNJ: Isolation and function of human dendritic cells. Int Rev Cytol 1994; 153:41-103.
7. Bendelac A: CD1: Presenting unusual antigens to unusual T lymphocytes. Science 1995; 269:185-186.
8. Porcelli SA: The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol 1995; 59:1-98.
9. Melian A, Beckman EM, Porcelli SA, Brenner M: Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr Opin in Immunol 1996; 8:82-88.
10. O'Doherty U, Steinman M, Peng, et al.:Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J Exp Med 1993; 178: 1067-1078.
11. O'Doherty U, Peng M, Gezelter S, et al.: Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82:487-493.
12. Thomas R, Davis LS, Lipsky PE: Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J Immunol 1993; 151: 6840-6852.
13. Thomas R, Davis LS, Lipsky PE: Isolation and characterization of human peripheral blood dendritic cells. J Immuno 1993; 150:821-834.
14. Weissman D, Li Y, Ananworanich J, et al.: Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1995; 92:826-830.
15. Zhou L-J, Tedder TF: Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 1995; 154:3821-3835.
16. Freudenthal PS, Steinman RM: The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 1990; 87:7698-7702.
17. Macatonia SE, Knight SC, Edwards AJ, Griffiths SG, Fryer P: Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 1987; 166:1654-1667.
18. Austyn JM, Kupiec-Weglinski JW, Hankins DF, Morris PJ: Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen and binding within marginal zone. J Exp Med 1988; 167:646-651.
19. Larsen CP, Steinman RM, Witmer-Pack MD, Hankins DF, Morris PJ, Austyn JM: Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172:1483-1494.
20. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C: Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145: 2833-2838.
21. Grouard G, Durand I, Filgueira L, Banchereau J, Liu YJ: Germinal centers contain hematopoietic-derived cells that strongly stimulate T lymphocytes. Nature 1996; 384:364-367.
22. Szakal AK, Holmes KL, Tew JG: Transport of immune complexes from the subcapsular sinus to lymph node follicles on the surface of nonphagocytic cells, including cells with dendritic morphology. J Immunol 1983; 131: 1714-1727.
23. Khoury SJ, Gallon L, Chen, et al.: Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendriticenriched cells induce specific peripheral T cell unresponsiveness in vivo. J Exp Med 1995; 182:357-366.
24. Ardavin C, Wu L, Li CL, Shortman K: Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 1993; 362:761-763.
25. Galy A, Travis M, Cen D, Chen B: Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995; 3:459-473.
26. Suss G, Shortman K: A subclass of dendritic cells kills CD4 T cells via Fas/ Fas-Ligand-induced apoptosis. J Exp Med 1996; 183:1789-1796.
27. Inaba K, Steinman RM, Pack MW, et al.: Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 1992; 175:1157-1167.
28. Inaba K, Inaba M, Romani N, et al.: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176:1693-1702.
29. Inaba K, Inaba M, Naito M, Steinman RM: Dendritic cells progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993; 178:479-488.
30. Inaba K, Inaba M, Deguchi, et al.: Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA 1993; 90:3038-3042.
31. Lu L, Woo J, Rao AS, et al.: Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/ macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179:1823-1834.
32. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW: Granulocyte/ macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60:1366-1370.
33. Lu L, McCaslin D, Starzl TE, Thomson AW: Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60:1539-1545.
34. Mayordomo JI, Zorina T, Storkus WJ, et al.: Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med 1995; 1:1297-1302.
35. Zitvogel L, Mayordomo JI, Tjandrawan T, et al.: Therapy of murine tumors with tumor peptide pulsed dendritic cells: dependence on T cells, B7 costimulation, and Th1-associated cytokines. Journal Exp Med 1996; 183:87-97.
36. Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP: Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell Immunol 1996; 170:111-119.
37. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-1118.
38. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down-regulation by cytokines and bacterial products. J Exp Med 1995; 182:389-400.
39. Romani N, Gruner S, Brang D, et al.: Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180:83-93.
40. Zhou L-J, Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996; 93:2588-2592.
41. + hematopoietic progenitor cells. Blood 1990; 75:2292-2298.
42. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-a cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360:258-261.
43. Young JW, Szabolcs P, Moore MAS: Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med 1995; 182: 1111-1120.
44. + bone marrow precursors cultured with c-kit-ligand, GM-CSF, and TNFα. J Immunol 1995; 154: 5851-5861.
45. Mackensen A, Herbst B, Köhler G, et al.: Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro. Blood 1995; 86:2699-2707.
46. Fisch P, Köhler G, Garbe A, et al.: Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patients. Eur J Immunol 1996; 26:595-600.
47. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE: TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukocyte Biol 1992; 52:274-281.
48. Santiago-Schwarz F, Divaris N, Kay C, Carsons SE: Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. Blood 1993; 82:3019-3028.
49. + progenitors in human bone marrow. J Immunol 1992; 149:2681-2688.
50. Strunk D, Rappersberger K, Egger C, et al.: Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 1996; 87:1292-1302.
51. Rosenzwajg M, Canque B, Gluckman JC: Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 1996; 87:535-544.
52. Strobl H, Riedl E, Scheinecker C, et al.: TGF-B1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol 1996; 157: 1499-1507.
53. Caux C, Vanbervliet B, Massacrier C, et al.: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+ TNFa. J Exp Med 1996; 184:695-706.
54. Szabolcs P, Avigan D, Gezelter S, et al.: Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-CFU intermediate. Blood 1996; 87:4520-4530.
55. Burkly L, Hession C, Ogata L, et al.: Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995; 373:531-536.
56. Nomori H, Watanabe S, Nakajima T, Shimosato Y, Kameya T: Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer 1986; 57:100-105.
57. Gallo O, Libonati GA, Gallina E, et al.: Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1991; 117:1007-1010.
58. Furukawa T, Watanabe S, Kodama T, Sato Y, Shimosato Y, Suemasu K: T-zone histiocytes in adenocarcinoma of the lung in relation to postoperative prognosis. Cancer 1985; 56:2651-2656.
59. Tsujitani S, Furukawa T, Tamada R, Okamura T, Yasumoto K, Sugimashi K: Langerhans cells and prognosis in patients with gastric carcinoma. Cancer 1987; 59:501-505.
60. Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimachi K: Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric carcinoma. Cancer 1990; 66:2012-2016.
61. Ambe K, Mori M, Enjoji M: S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Cancer 1989; 63:496-503.
62. Schröder S, Schwarz W, Rehpenning W, Löning T, Böcker W: Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinoma. Am J Clin Pathol 1988; 89:295-300.
63. Meissner K, Michaelis K, Rehpenning W, Löning T: Epidermal Langerhans cell densities influence survival in mycosis fungoides and Sézary syndrome. Cancer 1990; 65:2069-2073.
64. Gatter KC, Morris HB, Roach B, Mortimer P, Fleming KA, Mason DY: Langerhans cells and T cells in human skin tumors: an immunohistological study. Histopathology 1984; 8:229-244.
65. Dranoff G, Jaffee E, Lazenby A, et al.: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and longlasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90:3539-3543.
66. Pardoll DM: Paracrine cytokine adjuvants in cancer immunotherapy. Ann Rev Immunol 1995; 13:399-415.
67. Huang AYC, Golumbeck P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H: Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994; 264:961-965.
68. Tas M, Simons P, Balm F, Drexhage H: Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones. Cancer Immunol Immunother 1993; 36:108-114.
69. Erroi A, Casali B, Donati MB, Mantovani A, Semeraro N: Mouse tumor-associated macrophages do not generate procoagulant activity in response to different stimuli. J Int Cancer 1988; 41:65-68.
70. Chaux P, Martin MS, Martin F: Defect of the CTLA4-Ig ligands on tumor-infiltrating dendritic cells. Adv Exp Med Biol 1995; 378:389-392.
71. Caux C, Massacrier C, Vanbervliet B, Barthélémy C, Lui YJ, Banchereau J: Interleukin-10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 1994; 6:1177-1185.
72. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M: Cell migration, chimerism, and graft acceptance. Lancet 1992; 339:1579-1582.
73. Starzl TE, Demetris AJ, Trucco M, et al.: Cell migration chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993; 17:1153-1156.
74. Grabbe S, Bruvers S, Gallo RL, Knisely TL, Nazareno R, Granstein RD: Tumor antigen presentation by murine epidermal cells. J Immunol 1991; 146:3656-3661.
75. Flamand V, Sornasse T, Thielemans K, et al.: Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. J Eur Immunol 1994; 24:605-610.
76. Cohen PJ, Cohen PA, Rosenberg SA, Katz SI, Mule JJ: Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. J Eur Immunol 1994; 24:315-319.
77. Porgador A, Gilboa E: Bone marrowgenerated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 1995; 182:255-260.
78. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD: Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 1996; 183:283-287.
79. Falo LD, Kovacsovics-Bankowski M, Thompson K, Rock KL: Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nature Med 1995; 1:649-653.
80. Paglia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime CTL against tumor antigen in vivo. J Exp Med 1996; 183:317-322.
81. Storkus WJ, Zeh HJ, Maeurer MJ, Salter RD, Lotze MT: Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol 1993; 151:3719-3727.
82. Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996; 184: 465-472.
83. Hsu FJ, Benike C, Fagnoni F, et al.: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 1996; 2:52-58.
84. Mukherji B, Chakraborty NG, Yamasaki S, et al.: Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc Natl Acad Sci USA 1995; 92:8078-8082.
85. Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM: Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest 1994; 94:797-807.
86. Bhardwaj N, Seder RA, Reddy A, Feldman MV: IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. J Clin Invest 1996; 98:715-722.
87. Bender A, Bui LK, Feldman MAV, Larsson M, Bhardwaj N: Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med 1995; 182: 1663-1671.